Harrow (HROW) Total Debt Growth (3y) (2017 - 2026)
Harrow (HROW) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -7.03% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 11.29% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -12.80% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 72.82% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -4.66% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Harrow | 1.40 Bn | 1.31 Bn | 27.05 Mn | 20.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.04% |
| Dec 31, 2025 | 32.66% |
| Sep 30, 2025 | 49.81% |
| Jun 30, 2025 | -18.86% |
| Mar 31, 2025 | 16.12% |
| Dec 31, 2024 | 45.24% |
| Sep 30, 2024 | 46.15% |
| Jun 30, 2024 | 37.44% |
| Mar 31, 2024 | 155.85% |
| Dec 31, 2023 | 138.88% |
| Sep 30, 2023 | 133.57% |
| Jun 30, 2023 | 130.74% |
| Mar 31, 2023 | 144.13% |
| Dec 31, 2022 | 104.29% |
| Sep 30, 2022 | 77.74% |
| Jun 30, 2022 | 74.76% |
| Mar 31, 2022 | 82.07% |
| Dec 31, 2021 | 77.94% |
| Sep 30, 2021 | 78.01% |
| Jun 30, 2021 | 75.10% |